Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex

L Liu, R Jin, J Duan, L Yang, Z Cai, W Zhu, Y Nie, J He… - Acta Biomaterialia, 2020 - Elsevier
Iron oxide nanoparticles (IONPs) have been widely used as contrast agents for magnetic
resonance imaging (MRI) and other biomedical applications in both clinical and preclinical …
被引用次数：50 相关文章

Bioactive Iron Oxide Nanoparticles Suppress Osteoclastogenesis and Ovariectomy-Induced Bone Loss Through Regulating the TRAF6-p62-CYLD Signaling Complex

L Liu, R Jin, J Duan, L Yang, Z Cai, W Zhu… - Available at SSRN … - papers.ssrn.com
Iron oxide nanoparticles (IONPs) have been widely used as contrast agents for magnetic
resonance imaging (MRI) and other biomedical applications in both clinical and preclinical …

Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex

L Liu, R Jin, J Duan, L Yang, Z Cai, W Zhu… - Acta …, 2020 - pubmed.ncbi.nlm.nih.gov
Iron oxide nanoparticles (IONPs) have been widely used as contrast agents for magnetic
resonance imaging (MRI) and other biomedical applications in both clinical and preclinical …

Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.

L Liu, R Jin, J Duan, L Yang, Z Cai, W Zhu, Y Nie… - Acta …, 2019 - europepmc.org
Iron oxide nanoparticles (IONPs) have been widely used as contrast agents for magnetic
resonance imaging (MRI) and other biomedical applications in both clinical and preclinical …